Skip to content
lifestyle.sourcefed.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
AS2Bio
MavriX Bio Announces FDA Rare Pediatric Disease Designation for Investigational MVX-220 for the Treatment of Angelman Syndrome
October 1, 2026
FAST Awards Grant to Nobel Laureate Frances Arnold to Advance Next-Generation Tools for a Novel Therapeutic Strategy for Angelman Syndrome
July 20, 2026